Prospective Sinonasal Cancer Multi-institution Study

Description

This is a multi-institution prospective study of patients with sinonasal malignancies. The goal of this study is to learn more about the course of sinonasal cancer, treatment outcomes, and patient quality of life. In addition, central mutational and genomic analysis of tumor tissue will be evaluated.

Conditions

Sinonasal Carcinoma

Study Overview

Study Details

Study overview

This is a multi-institution prospective study of patients with sinonasal malignancies. The goal of this study is to learn more about the course of sinonasal cancer, treatment outcomes, and patient quality of life. In addition, central mutational and genomic analysis of tumor tissue will be evaluated.

Sinonasal Cancer Study to Evaluate Oncologic Outcomes and Quality of Life

Prospective Sinonasal Cancer Multi-institution Study

Condition
Sinonasal Carcinoma
Intervention / Treatment

-

Contacts and Locations

Rochester

Mayo Clinic in Rochester, Rochester, Minnesota, United States, 55905

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Subjects between the ages of 30 days (non-inclusive) and 99 years (inclusive)
  • * Patients with a diagnosis of sinonasal cancer
  • * Patients undergoing treatment at Mayo Clinic
  • * Healthy individuals
  • * Unwilling to sign the informed consent

Ages Eligible for Study

30 Days to 99 Years

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Mayo Clinic,

Carlos Pinheiro Neto, MD, PhD, PRINCIPAL_INVESTIGATOR, Mayo Clinic

Study Record Dates

2031-01